VP

Vinod Pralhad Dukare

Director DIN 06646854
DIN 06646854 First appointment Aug 2013
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Vinod Pralhad Dukare

Data last updated:

Vinod Pralhad Dukare was a Director at Epidote Pharmaceutical Private Limited (from 2013) and Director at Kshrugal Properties Private Limited (from 2014).

DIN 06646854
First Appointment 16 Aug 2013
Oldest Company Age 13 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Aug 20132013Strike Off
Kshrugal Properties Private Limited U45203MH2014PTC254106
Director11 Mar 20142014₹82.6 Lakh (FY 2016)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Epidote Pharmaceutical Private Limited
Kshrugal Properties Private Limited
Premium access

Shareholding and investment profile for Vinod Pralhad Dukare

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vinod Pralhad Dukare

Vinod Pralhad Dukare was first appointed on 16 Aug 2013 as Director at Epidote Pharmaceutical Private Limited. The most recent appointment on record is 11 Mar 2014 at Kshrugal Properties Private Limited.

Vinod Pralhad Dukare held 2 earlier board appointments: Epidote Pharmaceutical Private Limited (Director, from 16 Aug 2013); Kshrugal Properties Private Limited (Director, from 11 Mar 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available